AbCellera Biologics Inc. (ABCL)
NASDAQ: ABCL · Real-Time Price · USD
4.160
0.00 (0.00%)
At close: Apr 28, 2026, 4:00 PM EDT
4.190
+0.030 (0.72%)
After-hours: Apr 28, 2026, 7:59 PM EDT
AbCellera Biologics Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Apr '26 Apr 28, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Market Capitalization | 1,261 | 1,024 | 865 | 1,657 | 2,898 | 4,027 | |
| Market Cap Growth | 76.34% | 18.29% | -47.77% | -42.83% | -28.02% | -62.83% | |
| Enterprise Value | 871 | 670 | 294 | 952 | 2,106 | 3,305 | |
| Last Close Price | 4.16 | 3.42 | 2.93 | 5.71 | 10.13 | 14.30 | |
| PE Ratio | - | - | - | - | 18.28 | 26.24 | |
| Forward PE | - | - | - | - | - | 51.81 | |
| PS Ratio | 16.79 | 13.63 | 30.02 | 43.57 | 5.97 | 10.73 | |
| PB Ratio | 1.29 | 1.06 | 0.82 | 1.44 | 2.35 | 3.93 | |
| P/TBV Ratio | 1.43 | 1.16 | 0.90 | 1.68 | 2.75 | 4.85 | |
| P/FCF Ratio | - | - | - | - | 14.02 | 21.63 | |
| P/OCF Ratio | - | - | - | - | 10.45 | 16.46 | |
| EV/Sales Ratio | 11.59 | 8.92 | 10.19 | 25.03 | 4.34 | 8.81 | |
| EV/EBITDA Ratio | - | - | - | - | 8.62 | 15.10 | |
| EV/EBIT Ratio | - | - | - | - | 9.36 | 16.17 | |
| EV/FCF Ratio | - | - | - | - | 10.19 | 17.76 | |
| Debt / Equity Ratio | 0.15 | 0.15 | 0.06 | 0.07 | 0.07 | 0.04 | |
| Debt / EBITDA Ratio | - | - | - | - | 0.32 | 0.18 | |
| Debt / FCF Ratio | - | - | - | - | 0.40 | 0.22 | |
| Net Debt / Equity Ratio | -0.40 | -0.40 | -0.53 | -0.59 | -0.65 | -0.67 | |
| Net Debt / EBITDA Ratio | 2.00 | 2.00 | 2.50 | 3.21 | -3.29 | -3.12 | |
| Net Debt / FCF Ratio | 2.24 | 2.24 | 3.00 | 5.66 | -3.89 | -3.67 | |
| Asset Turnover | 0.06 | 0.06 | 0.02 | 0.03 | 0.34 | 0.32 | |
| Inventory Turnover | - | - | - | - | 108.81 | 69.86 | |
| Quick Ratio | 10.07 | 10.07 | 8.95 | 6.93 | 8.37 | 7.44 | |
| Current Ratio | 11.32 | 11.32 | 9.81 | 7.33 | 8.67 | 7.71 | |
| Return on Equity (ROE) | -14.47% | -14.47% | -14.75% | -12.27% | 14.03% | 16.54% | |
| Return on Assets (ROA) | -9.99% | -9.99% | -12.41% | -9.79% | 9.83% | 10.99% | |
| Return on Invested Capital (ROIC) | -36.58% | -40.50% | -58.61% | -52.82% | 38.64% | 49.05% | |
| Return on Capital Employed (ROCE) | -16.80% | -16.80% | -22.00% | -17.30% | 15.80% | 17.10% | |
| Earnings Yield | -11.61% | -14.30% | -18.82% | -8.84% | 5.47% | 3.81% | |
| FCF Yield | -13.80% | -17.00% | -21.60% | -7.29% | 7.13% | 4.62% | |
| Buyback Yield / Dilution | -1.49% | -1.49% | -1.79% | 8.15% | 1.09% | -20.96% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.